Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The More Life CompanyFRA:20MP Dividend Yield % is 0.00% as of Aug. 23, 2026. The stock has 3 warning signs investors should review. Among 507 Drug Manufacturers companies, The More Life Company ranks worse than 197238.46% on this metric.
As of today (2026-08-23), the Trailing Annual Dividend Yield of The More Life Company is 0.00%.
The historical rank and industry rank for The More Life Company's Dividend Yield % or its related term are showing as below:
FRA:20MP's Dividend Yield % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 1.97 * Ranked among companies with meaningful Dividend Yield % only.
The More Life Company (FRA:20MP) Dividend Yield % Explanation
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
The More Life Company Dividend Yield % Related Terms
The More Life Company Dividend Yield % Historical Data
* Premium members only.
The historical data trend for The More Life Company's Dividend Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, The More Life Company's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
The More Life Company Dividend Yield % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, The More Life Company's Dividend Yield % distribution charts can be found below:
* The bar in red indicates where The More Life Company's Dividend Yield % falls into.
The More Life Company (FRA:20MP) has a Dividend Yield % of 0.00% as of Aug. 23, 2026. Dividend yield is the ratio of company dividends to the share price. View historical data on The More Life Company and its competitors. According to the industry distribution chart, The More Life Company ranks #999999 out of 507 companies in the Drug Manufacturers industry.
Is The More Life Company's Dividend Yield % too high?
The More Life Company's current Dividend Yield % is 0.00%. Based on the distribution chart, The More Life Company ranks #999999 out of 507 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers.
How does The More Life Company's Dividend Yield % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, The More Life Company ranks #999999 out of 507 companies for Dividend Yield %. This places The More Life Company in the lower half of its industry. The industry median Dividend Yield % is 1.97. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Yield % for a Drug Manufacturers company?
The median Dividend Yield % among Drug Manufacturers companies is 1.97, based on 507 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Yield % mean?
A high Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Dividend yield is the ratio of company dividends to the share price. View historical data on The More Life Company and its competitors. For the Drug Manufacturers industry, the median Dividend Yield % is 1.97 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. The More Life Company's current Dividend Yield % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is The More Life Company stock overvalued right now?
The More Life Company (FRA:20MP) has a current Dividend Yield % of 0.00%. The current Dividend Yield % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Yield % calculated?
Dividend Yield % is calculated from a company's financial statements. For The More Life Company (FRA:20MP), the current Dividend Yield % is 0.00% as of Aug. 23, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Mountain Valley MD Holdings Inc is a Canada-based company. The firm, along with its subsidiaries, is engaged in implementing its Quicksome oral delivery technologies across a variety of molecules in nutraceutical, vaccine, and pharmaceutical drug applications. The company actively invests in and collaborates on pioneering biotechnologies that have the potential to revolutionize the human health and wellness landscape, drive sustainable increases in plant yields and agricultural farming practices, and broadly support animal husbandry health. The Company is a biotech company focused on advancing solutions to optimize human, animal, and plant health.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:20MP has been successfully added to your 
